Will bevacizumab biosimilars impact the value of systemic therapy in gynecologic cancers?
Overview of attention for article published in Gynecologic Oncology Research and Practice, March 2017
Altmetric Badge
About this Attention Score
-
Above-average Attention Score compared to outputs of the same age (53rd percentile)
Readers on
- mendeley
- 36 Mendeley